| Androgen-dependent mammary carcinogenesis in rats transgenic for the Neu proto-oncogene. | None |
| crosstalk between the Neu proto-oncogene and androgen receptor signaling pathways in the growth of both the normal and cancerous mammary epithelium | None |
| ErbB2 oncogene expression supports the acute pancreatitis-chronic pancreatitis sequence. | None |
| The Epstein-Barr virus nuclear antigen-1 may act as a transforming suppressor of the HER2/neu oncogene. | None |
| HER-2/neu oncogene sequence revisited. | None |
| Comparison of proto-oncogenic and mutant forms of the transmembrane region of the Neu receptor in TFE. | None |
| In spite of missing correlation between survival and her-2/ neu overexpression in our study, the predictive value of the her-2/ neu protooncogene in adjuvant therapy in OSCC needs further investigation. | None |
| [Evaluation of her-2/neu amplification/overexpression in OSCC with fluorescence in situ hybridization (FISH) and immunohistochemistry]. | None |
| HER2 oncogene amplification in extramammary Paget s disease. | None |
| Activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER-2/neu proto-oncogene. | None |
| Expression of cytokeratin and erbB-2 oncoprotein in Paget s disease of the nipple. An immunohistochemical study. | None |
| Transcriptional targeting of the HER-2/neu oncogene. | None |
| Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues. | None |
| Molecular dynamics simulations of the transmembrane domain of the oncogenic ErbB2 receptor dimer in a DMPC bilayer. | None |
| Expression of the c-ErbB-2/HER2 proto-oncogene in normal hematopoietic cells. | None |
| [The search for amplification of the ERBB-2 oncogene in human tumors]. | None |
| Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene. | None |
| Expression and amplification of neu oncogene in pleomorphic adenomas of salivary gland. | None |
| Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene. | None |
| Human c-erbB-2 proto-oncogene product as a target for bispecific-antibody-directed adoptive tumor immunotherapy. | None |